Novel bio-adhesive hemostatics, "PyteQ", was developed, and now available. Animal clinical studies are ongoing with Exosomes- and DNA-Vaccines against tumors. Looking for Partners for Production, Sale & Joint Development
Secretariat of Regenerative Medicine Japan
c/o JTB Communication Design, Inc.
Celestine Shiba Mitsui Building, 3-23-1, Shiba, Minato-ku, Tokyo, Japan 105-8335
The Partnering system is entirely shared between Regenerative Medicine Japan and BioJapan, so participants can now reach an even wider range of potential partners than ever before.
Asia's No.1 biotechnology event!